Jin Yang Pharmaceutical Co. Ltd - Asset Resilience Ratio
Jin Yang Pharmaceutical Co. Ltd (007370) has an Asset Resilience Ratio of 1.23% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2025)
This chart shows how Jin Yang Pharmaceutical Co. Ltd's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Jin Yang Pharmaceutical Co. Ltd to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Jin Yang Pharmaceutical Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Jin Yang Pharmaceutical Co. Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩3.35 Billion | 1.23% |
| Total Liquid Assets | ₩3.35 Billion | 1.23% |
Asset Resilience Insights
- Limited Liquidity: Jin Yang Pharmaceutical Co. Ltd maintains only 1.23% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Jin Yang Pharmaceutical Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Jin Yang Pharmaceutical Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 48.48% |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
Drug Manufacturers - Specialty & Generic | 11.69% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 4.31% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 15.57% |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
Drug Manufacturers - Specialty & Generic | 24.59% |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550 |
Drug Manufacturers - Specialty & Generic | 18.70% |
Annual Asset Resilience Ratio for Jin Yang Pharmaceutical Co. Ltd (2014–2025)
The table below shows the annual Asset Resilience Ratio data for Jin Yang Pharmaceutical Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 1.38% | ₩3.68 Billion ≈ $2.50 Million |
₩267.81 Billion ≈ $181.49 Million |
+0.49pp |
| 2024-12-31 | 0.88% | ₩2.01 Billion ≈ $1.36 Million |
₩227.57 Billion ≈ $154.22 Million |
-6.28pp |
| 2023-12-31 | 7.17% | ₩8.60 Billion ≈ $5.82 Million |
₩119.91 Billion ≈ $81.26 Million |
-2.00pp |
| 2022-12-31 | 9.17% | ₩10.49 Billion ≈ $7.11 Million |
₩114.44 Billion ≈ $77.56 Million |
-5.93pp |
| 2021-12-31 | 15.10% | ₩14.87 Billion ≈ $10.08 Million |
₩98.50 Billion ≈ $66.75 Million |
+7.28pp |
| 2020-12-31 | 7.82% | ₩5.33 Billion ≈ $3.61 Million |
₩68.08 Billion ≈ $46.13 Million |
+0.75pp |
| 2019-12-31 | 7.07% | ₩4.83 Billion ≈ $3.27 Million |
₩68.28 Billion ≈ $46.27 Million |
+3.81pp |
| 2018-12-31 | 3.26% | ₩2.29 Billion ≈ $1.55 Million |
₩70.06 Billion ≈ $47.48 Million |
+1.22pp |
| 2017-12-31 | 2.04% | ₩1.51 Billion ≈ $1.02 Million |
₩73.85 Billion ≈ $50.05 Million |
+1.07pp |
| 2016-12-31 | 0.97% | ₩746.86 Million ≈ $506.14K |
₩76.78 Billion ≈ $52.04 Million |
-1.33pp |
| 2015-12-31 | 2.30% | ₩2.00 Billion ≈ $1.36 Million |
₩86.90 Billion ≈ $58.89 Million |
-5.52pp |
| 2014-12-31 | 7.82% | ₩6.00 Billion ≈ $4.07 Million |
₩76.68 Billion ≈ $51.97 Million |
-- |
About Jin Yang Pharmaceutical Co. Ltd
Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers crivix tablets, Eszol tablets, atolan tablets, prescription drugs, and over-the-counter drugs. It also offers antilipidemic, antiplatelet, gastrointestinal, and respiratory agents; antithrombotics; NSAIDs; menopause symptoms treatment; and stomatological products. The company also exports i… Read more